Azenta Inc (AZTA)

Currency in USD
45.15
-0.50(-1.10%)
Real-time Data·
AZTA is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
44.3245.48
52 wk Range
15.9350.06
Key Statistics
Prev. Close
45.65
Open
44.32
Day's Range
44.32-45.48
52 wk Range
15.93-50.06
Volume
66.92K
Average Volume (3m)
1M
1-Year Change
52.4706%
Book Value / Share
31,89
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
AZTA Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
52.60
Upside
+16.50%
Members' Sentiments
Bearish
Bullish
ProTips
Holds more cash than debt on its balance sheet

Azenta Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Buy
Moving Averages
Strong Buy

Analyst Ratings

3 Buy
3 Hold
0 Sell
Ratings:
6 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 52.60
(+16.50% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate
Jefferies
Buy52.00+14.64%44.00MaintainNov 11, 2026
Jefferies
Buy36.00-20.63%30.00MaintainAug 05, 2026
Needham
Buy37.00-18.43%33.00MaintainAug 05, 2026
Jefferies
Buy30.00-33.86%35.00MaintainMay 06, 2026
Evercore ISI
Buy35.00-22.84%45.00MaintainApr 06, 2026

Azenta Inc Earnings Call Summary for Q4/2026

  • Azenta Q4 non-GAAP EPS of $0.28 beat estimates by 133%, revenue of $167M topped forecasts; shares surged 9.6% to near 52-week highs.
  • FY2027 guidance projects 3-5% organic revenue growth to $648-660M with 200-250 bps adjusted EBITDA margin expansion from cost savings.
  • Company reshaping multiomics via exclusive Elegen license and SynPlexity acquisition to capture AI-enabled drug discovery market growth.
  • Sample management to drive mid-single-digit growth; automated stores recovery underway with improved bookings and new product launches planned late FY2027.
  • Strong balance sheet with $506M cash, no debt; repurchased $118M in shares during FY2026 despite below-target $27M free cash flow performance.
Last Updated: 2026/11/11, 16:40
Read Full Transcript

Earnings

Latest Release
Nov 10, 2026
EPS / Forecast
0,28 / 0,12
Revenue / Forecast
167M / 160,32M
EPS Revisions
Last 90 days

AZTA Income Statement

Compare AZTA to Peers and Sector

Metrics to compare
AZTA
Peers
Sector
Relationship
P/E Ratio
−12.1x−15.5x−0.2x
PEG Ratio
0.060.050.00
Price/Book
1.4x5.1x2.6x
Price / LTM Sales
3.1x9.8x2.8x
Upside (Analyst Target)
15.2%17.1%65.0%
Fair Value Upside
Unlock−3.2%9.5%Unlock

Azenta, Inc. provides biological and chemical compound sample exploration and management solutions for the life sciences industry in the United States, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally. It operates through Sample Management Solutions and Multiomics segments. The Sample Management Solutions segment provides sample management products and services, including automated stores, cryogenic systems, automated sample tubes, consumables and instruments, and controlled rate thawing devices, as well as sample repository services. This segment also offers consultation services to clients throughout their experimental design and implementation processes. The Multiomics segment provides genomic and other sample analysis services comprising gene sequencing, gene synthesis, and related services. The company has a strategic partnership with Frontier Space Ltd to conduct scientific experiments in space. The company was formerly known as Brooks Automation, Inc. and changed its name to Azenta, Inc. in December 2021. Azenta, Inc. was founded in 1978 and is headquartered in Burlington, Massachusetts.

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
21,61M51,76%986,60M
Other Institutional Investors
28,84M48,24%1,32B
Public Companies & Retail Investors
0,000,00%0,00
Total
50,45M100,00%2,3B

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
BlackRock, Inc.18,03%7 529 450343 719
Politan Capital Management, L.P.11,07%4 622 450211 015

FAQ

What Is the Azenta (AZTA) Stock Price Today?

The Azenta stock price today is 45,15 USD.

What Stock Exchange Does Azenta Trade On?

Azenta is listed and trades on the Nasdaq Stock Exchange.

What Is the Stock Symbol for Azenta?

The stock symbol for Azenta is "AZTA."

What Is the Azenta Market Cap?

As of today, Azenta market cap is 1,89B USD.

What Is Azenta's Earnings Per Share (TTM)?

The Azenta EPS (TTM) is -3,50.

When Is the Next Azenta Earnings Date?

Azenta will release its next earnings report on Feb 10, 2027.

From a Technical Analysis Perspective, Is AZTA a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has Azenta Stock Split?

Azenta has split 0 times.

How Many Employees Does Azenta Have?

Azenta has 2900 employees.

What is the current trading status of Azenta (AZTA)?

As of Nov 16, 2026, Azenta (AZTA) is trading at a price of 45,15 USD, with a previous close of 45,65 USD. The stock has fluctuated within a day range of 44,32 USD to 45,48 USD, while its 52-week range spans from 15,93 USD to 50,06 USD.

What Is Azenta (AZTA) Price Target According to Analysts?

The average 12-month price target for Azenta is 52,60 USD, with a high estimate of 57 USD and a low estimate of 50 USD. 3 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Buy. The stock has an +16,50% Upside potential.

What Is the AZTA Premarket Price?

AZTA's last pre-market stock price is 45,21 USD. The pre-market share volume is 6 680,00, and the stock has decreased by -0,44, or -0,96%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.